Although the goal of cancer treatment is to improve the quantity and quality of life,123 clinical trials designed to gain regulatory approval for new drugs often evaluate indirect or “surrogate” measures of drug efficacy. These endpoints show that an agent has biological activity, but they are not reliable surrogates for improved survival4567891011 or quality of life46111213
1More
1More
North America the leading Gluten Free Products Market - 0 views
1More
What is Driving the Gluten-Free Products Market - 0 views
1More
Drug Delivery Technology Market is worth $224.2 Billion By 2017 - 0 views
1More
North America Injectable Drug Delivery Market - 0 views
1More
Disinfection Segment Touches New Highs by Leading the Infection Control Market - 0 views
25More
PLOS ONE: Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Ther... - 0 views
1More
Karman Ergo Lite S-2501 Wheelchair - 0 views
1More
New extrusion coating line from Davis-Standard targets flexible packaging market - 0 views
1More